Understanding molecular mechanism leading to addiction in humans
News Aug 05, 2015
A new study just published in the journal Molecular Psychiatry by the team led by Salah El Mestikawy, Ph.D., researcher at the Douglas Mental Health University Institute (CIUSSS de l'Ouest-de-l'île-de-Montréal), professor at McGill University in Montreal, Quebec and head of research at CNRS INSERM UPMC in Paris, opens the field to new understanding of the molecular mechanism underlying addiction in humans.
This work was accomplished through collaboration with several international research teams. Among these researchers was Stéphane Jamain (CR1 INSERM, Université de Créteil, France), a French geneticist specializied in psychiatric disorders.
The research explained in simple terms
To communicate with each other, neurons use neurotransmitters. Among the classical neurotransmitters are dopamine, serotonin, acetylcholine and glutamate. Until recently, it was believed that a given neuron used only one classical neurotransmitter. Some time ago, Salah El Mestikawy's team contributed to the surprising discovery that subpopulations of neurons are able to use two transmitters. In other words, unlike the vast majority of neurons, these neurons are bilingual. Most neurons in the brain respond with either "yes," "no" or "maybe." El Mestikawy and his colleagues found that in order to regulate our reward behaviors, a small population of neurons in our reward center are able to respond with both "yes" and "no." These neurons are known as cholinergic neurons, while the reward center is known as the nucleus accumbens. In this new work, the researchers discovered that when they shut down one of the languages (the "no") of cholinergic neurons within the reward center, mice showed a marked predilection for cocaine. This work explains the molecular mechanism underlying reward behavior, while identifying an unsuspected target in the treatment of addiction.
Finally and perhaps even more important, the team found that humans with mutation of a key gene for this co-transmission were 10 times more vulnerable to very severe forms of addiction.
"These discoveries are bringing about a major transformation in the field of addiction. We are beginning to decipher and understand the complex regulation of basic behaviors" says Salah El Mestikawy.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
El Mestikawy S et al. The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens. Molecular Psychiatry, Published August 4 2015. doi: 10.1038/mp.2015.104
Researchers Find a Way to Separate Side Effects of Opioid Drugs Reducing RiskNews
Scientists have discovered a way to separate these two effects -- pain relief and breathing, opening a window of opportunity to make effective pain medications without the risk of respiratory failure.READ MORE
Biological Mechanism of a Leading Cause of Childhood Blindness RevealedNews
Scientists have revealed the pathology of cells and structures stricken by optic nerve hypoplasia, a leading cause of childhood blindness in developed nations.READ MORE
Machine Learning: Helping Determine How a Drug Affects the BrainNews
Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new UCL study published today in Brain.READ MORE